Our results suggested that CLPP/VSVMP mRNA complex was more capable than equal amount of plasmid complex in treating C26 colon cancer in vitro, with an inhibition rate of 70.6% versus 59.6% (P < 0.05, Fig. 4g). The gene discussed is CLPP; the disease is colonic neoplasm.